ReShape Lifesciences, Inc. (RSLS) Net Income by Year
ReShape Lifesciences, Inc. reported a net loss of $10.3M in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. The table below carries 12 fiscal years, from 2014 to 2025, and the quarters ReShape Lifesciences, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
RSLS Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
RSLS Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More ReShape Lifesciences, Inc. financials
Frequently Asked Questions
What was ReShape Lifesciences, Inc.'s net income in fiscal year 2025?
ReShape Lifesciences, Inc. reported a net loss of $10.3M in fiscal year 2025.
How fast is ReShape Lifesciences, Inc.'s net income growing?
ReShape Lifesciences, Inc. (RSLS) reported a $1.4M net loss in fiscal year 2024 and a $10.3M net loss in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.
How has ReShape Lifesciences, Inc.'s net income changed over the years?
Across the 12 fiscal years this page covers, ReShape Lifesciences, Inc. (RSLS) net income went from -$9.9M in fiscal year 2014 to -$10.3M in fiscal year 2025.
What was ReShape Lifesciences, Inc.'s net income in the most recent quarter?
ReShape Lifesciences, Inc. (RSLS) reported -$963K in net income in Q1 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what ReShape Lifesciences, Inc. (RSLS) reported on that line in every period on record.